About OBSOLETE: Melanoma-pancreatic cancer syndrome
OBSOLETE: Melanoma-pancreatic cancer syndrome is a rare disease catalogued by Orphanet (ORPHA:51013). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Melanoma-pancreatic cancer syndrome trials.
Search ClinicalTrials.gov for "OBSOLETE: Melanoma-pancreatic cancer syndrome" or Orphanet code ORPHA:51013 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Melanoma-pancreatic cancer syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Melanoma-pancreatic cancer syndrome. Updated daily.